Molecular Diagnostics Market | 2021 Global Analysis By Size, Growth Insights, Developments, Emerging Technologies, Share, Key Players, Trends, Regional Outlook And Global Industry Forecast To 2025 is latest study published by Fortune Business Insights. The Global Molecular Diagnostics Industry expected to Reach USD 13.87 billion value, at CAGR of 7.1% by 2025. Molecular Diagnostics Industry is segmented By Product Type (Instruments Reagents & Consumables), By Application (Infectious Disease, Blood Screening, Histology & Oncology), By Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs), and Regional Forecast 2018-2025.
Get Sample Report On Global Molecular Diagnostics Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/molecular-diagnostics-market-100086
Key Companies Studied In Report:
- bioMérieux SA.
- BD
- Danaher Corporation
- Grifols, S.A.
- Hologic Inc.
- Novartis AG
- QIAGEN
- Siemens Healthcare GmbH
- Hoffmann-La Roche Ltd.
Global Molecular Diagnostics Market Highlights:
The increasing incidence of infectious diseases around the world is driving the global infectious disease molecular diagnostics market. Rising awareness regarding prevention and early diagnosis of sexually transmitted diseases is expected to aid the growth of the global infectious disease molecular diagnostics market.
Molecular diagnostics is an effective tool for the detection of HIV, HPV, and other infectious diseases. The increasing demand for molecular diagnostics is likely to boost the global infectious disease molecular diagnostics market revenue during the forecast period. Government support to tackle the rising cases of infectious diseases is predicted to further augment the growth of the global infectious disease molecular diagnostics market. The acquisitions and collaborations between key companies are also expected to contribute positively to the global infectious disease molecular diagnostics growth.
For instance, Bruker Corporation announced the acquisition of Hain Lifescience GmbH, an infectious disease molecular diagnostics company, to expand its footprint in molecular diagnostics. The launch of new molecular diagnostics platforms or instruments are likely to enable growth of the global infectious disease molecular diagnostics market. For instance, Qiagen announced the launch of QIAscreen HPV PCR Test, an in-vitro molecular diagnostics test for the detection of human papillomavirus in Europe.
Furthermore, the increasing prevalence of infectious diseases along with the rising awareness and shift towards personalized medicines and preventive care is expected to contribute to the global infectious disease diagnostic techniques shares. In 2017, According to the World Health Organization (WHO) there were approximately 36.9 million individuals diagnosed with HIV with an estimate of 1.8 million people diagnosed every year. These trends and factors together are predicted to uplift the infectious disease molecular diagnostics market shares in the forthcoming year. Nonetheless, high installation and infrastructure cost of Molecular diagnostics is likely to hinder the growth of the global disease molecular diagnostics market. In addition, lack of skilled labour in developing countries is expected to further restrict the growth of the global infectious disease molecular diagnostics market.
Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for Molecular Diagnostics market to figure out and study the market’s needs, market size, and competition.
Regional Analysis:
- North America (the USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East and Africa (South Africa, GCC and Rest of the Middle East and Africa)
Geographically, the global infectious disease molecular diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the global infectious disease molecular diagnostics market during the forecast period owing to the increasing prevalence of infectious diseases such as HIV and respiratory diseases. Established healthcare system and increasing R&D investment is also expected to enable the growth of the global infectious disease molecular diagnostics market. The global infectious disease molecular diagnostics market in Asia Pacific is predicted to grow at a significant rate during the forecast period due to the active government support and improving access to the advanced diagnostic facility. In addition, the rapid adoption of preventive care will also boost the infectious disease molecular diagnostics market in Asia Pacific.
This report focuses on Molecular Diagnostics Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
For More Questions, Talk with Molecular Diagnostics Industry Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/molecular-diagnostics-market-100086
Molecular Diagnostics Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
Competitive Analysis And Industry News:
Major companies in the global Molecular Diagnostics Market are increasingly focusing on research and development activities to create new and innovative products to stay ahead of the competition. Staying on top of market trends and drivers is crucial for decision-makers to hold this emerging opportunity. The study provides information on market trends and development, drivers, capacities, technologies, and the changing investment structure of the Molecular Diagnostics Industry.
Key questions answered in the report:
- What will the market growth rate of Molecular Diagnostics Market in 2025?
- What are the key factors driving the global Molecular Diagnostics Market?
- Who are the key manufacturers in Molecular Diagnostics Market space?
- What are the market opportunities, market risk and market overview of the Molecular Diagnostics Global market?
- What are sales, revenue, and price analysis of top manufacturers of Molecular Diagnostics Global market?
- What are sales, revenue, and price analysis by types and applications of Molecular Diagnostics Market?
- What are sales, revenue, and price analysis by regions of Molecular Diagnostics market?
Get customized Report: https://www.fortunebusinessinsights.com/enquiry/customization/molecular-diagnostics-market-100086
Table of Content:
1 Market Overview
1.1 Molecular Diagnostics Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2020-2025)
1.4.1.2 Canada Market States and Outlook (2020-2025)
1.4.1.3 Mexico Market States and Outlook (2020-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2020-2025)
1.4.2.2 France Market States and Outlook (2020-2025)
1.4.2.3 UK Market States and Outlook (2020-2025)
1.4.2.4 Russia Market States and Outlook (2020-2025)
1.4.2.5 Italy Market States and Outlook (2020-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2020-2025)
1.4.3.2 Japan Market States and Outlook (2020-2025)
1.4.3.3 Korea Market States and Outlook (2020-2025)
1.4.3.4 India Market States and Outlook (2020-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2020-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2020-2025)
1.4.4.2 Egypt Market States and Outlook (2020-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2020-2025)
1.4.4.4 South Africa Market States and Outlook (2020-2025)
1.4.4.5 Turkey Market States and Outlook (2020-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
3 Global Molecular Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Molecular Diagnostics Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Molecular Diagnostics Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Molecular Diagnostics Manufacturer Market Share in 2018
3.3.2 Top 6 Molecular Diagnostics Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Molecular Diagnostics Market Analysis by Regions
4.1 Global Molecular Diagnostics Sales, Revenue and Market Share by Regions
4.1.1 Global Molecular Diagnostics Sales and Market Share by Regions (2020-2025)
4.1.2 Global Molecular Diagnostics Revenue and Market Share by Regions (2020-2025)
4.2 North America Molecular Diagnostics Sales and Growth Rate (2020-2025)
4.3 Europe Molecular Diagnostics Sales and Growth Rate (2020-2025)
4.4 Asia-Pacific Molecular Diagnostics Sales and Growth Rate (2020-2025)
4.5 South America Molecular Diagnostics Sales and Growth Rate (2020-2025)
4.6 Middle East and Africa Molecular Diagnostics Sales and Growth Rate (2020-2025)
5 North America Molecular Diagnostics by Country
5.1 North America Molecular Diagnostics Sales, Revenue and Market Share by Country
5.1.1 North America Molecular Diagnostics Sales and Market Share by Country (2020-2025)
5.1.2 North America Molecular Diagnostics Revenue and Market Share by Country (2020-2025)
5.2 United States Molecular Diagnostics Sales and Growth Rate (2020-2025)
5.3 Canada Molecular Diagnostics Sales and Growth Rate (2020-2025)
5.4 Mexico Molecular Diagnostics Sales and Growth Rate (2020-2025)
8 South America Molecular Diagnostics by Country
8.1 South America Molecular Diagnostics Sales, Revenue and Market Share by Country
8.1.1 South America Molecular Diagnostics Sales and Market Share by Country (2020-2025)
8.1.2 South America Molecular Diagnostics Revenue and Market Share by Country (2020-2025)
8.2 Brazil Molecular Diagnostics Sales and Growth Rate (2020-2025)
8.3 Argentina Molecular Diagnostics Sales and Growth Rate (2020-2025)
8.4 Colombia Molecular Diagnostics Sales and Growth Rate (2020-2025)
9 Middle East and Africa Molecular Diagnostics by Countries
9.1 Middle East and Africa Molecular Diagnostics Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Molecular Diagnostics Sales and Market Share by Country (2020-2025)
9.1.2 Middle East and Africa Molecular Diagnostics Revenue and Market Share by Country (2020-2025)
9.2 Saudi Arabia Molecular Diagnostics Sales and Growth Rate (2020-2025)
9.3 Turkey Molecular Diagnostics Sales and Growth Rate (2020-2025)
9.4 Egypt Molecular Diagnostics Sales and Growth Rate (2020-2025)
9.5 Nigeria Molecular Diagnostics Sales and Growth Rate (2020-2025)
10 Molecular Diagnostics Market In Developing Countries
11 South America Molecular Diagnostics Market Analysis by Countries
12 Competitive Landscape
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Molecular Diagnostics Market Forecast
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
Continued…
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245